Esperion Therapeutics Inc
F:0ET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Esperion Therapeutics Inc
F:0ET
|
US |
|
NAPCO Security Technologies Inc
F:NS1
|
US |
|
B
|
BAE Systems PLC
XMUN:BSP
|
UK |
|
Hexagon Composites ASA
F:2HX
|
NO |
|
V
|
VersaBank
TSX:VBNK
|
CA |
|
Y
|
Yelp Inc
XBER:Y9L
|
US |
|
R
|
Rojukis International PCL
SET:KISS
|
TH |
Wall St Price Targets
0ET Price Targets Summary
Esperion Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0ET is 2.125 EUR with a low forecast of 1.288 EUR and a high forecast of 2.468 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0ET's stock price target?
Price Target
2.125
EUR
According to Wall Street analysts, the average 1-year price target for 0ET is 2.125 EUR with a low forecast of 1.288 EUR and a high forecast of 2.468 EUR.
What is the Revenue forecast for Esperion Therapeutics Inc?
Projected CAGR
3%
The compound annual growth rate for Revenue over the next 8 years is 3%.
What is the Gross Profit forecast for Esperion Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Gross Profit over the next 5 years is 29%.
What is the Operating Income forecast for Esperion Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 8 years is 28%.
